BA
ASTX

BlackRock Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

BlackRock Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-82,585
Closed -$701K – 3717
2013
Q3 		$701K Sell
82,585
-47,950
-37% -$303K ﹤0.01% 1665
2013
Q2 		$536K Buy
+130,535
New +$702K ﹤0.01% 1777

BlackRock Advisors's ASTX Position: Q4 2013 in Review

BlackRock Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 82,585 shares — an estimated $701K sold.

BlackRock Advisors first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $701K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BlackRock Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BlackRock Advisors sold 82,585 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $701K.
  • BlackRock Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BlackRock Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $701K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BlackRock Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.